Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...
South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...
Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...
The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...
South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...
South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...
On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...
Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...
The Netherlands Ministry of Health, Sports and Welfare has announced an additional EUR 14 million contribution to Norway...
South Korea-based SK bioscience recently announced that Dr Jean Kaseya, Director General, African Centers...
South Korea-based International Vaccine Institute (IVI) has partnered with KEMRI-Wellcome Trust Research Programme (KWTR...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...
Australia-based Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation fro...
As the world is progressively rebounding from pandemic impact, Moderna is constantly developing next-generation combinat...
The Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and the Roya...
